Table of Contents Author Guidelines Submit a Manuscript
Depression Research and Treatment
Volume 2012, Article ID 815363, 8 pages
http://dx.doi.org/10.1155/2012/815363
Research Article

Predictors of Treatment with Duloxetine or Venlafaxine XR among Adult Patients Treated for Depression in Primary Care Practices in the United Kingdom

1Thomson Reuters, Cambridge, MA 02140, USA
2Thomson Reuters, Washington, DC 20008, USA
3General Electric Healthcare, 2 Bethesda Metro Center, Bethesda, MD 20814, USA
4Eli Lilly and Company, Health Technology Appraisal Group, 61352 Bad Homburg, Germany

Received 5 January 2012; Revised 14 March 2012; Accepted 1 April 2012

Academic Editor: Charles B. Nemeroff

Copyright © 2012 Nianwen Shi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Nianwen Shi, Emily Durden, Amelito Torres, Zhun Cao, and Michael Happich, “Predictors of Treatment with Duloxetine or Venlafaxine XR among Adult Patients Treated for Depression in Primary Care Practices in the United Kingdom,” Depression Research and Treatment, vol. 2012, Article ID 815363, 8 pages, 2012. https://doi.org/10.1155/2012/815363.